| 摘要 |
The use of a compound of formula (I) or a pharmaceutically acceptable salt thereof for the treatment of artrial arrhythmia, stroke or CNS disorders X-CO-CH2-Z(I) wherein X is a monocyclic or polycyclic aromatic group, Z is of sub-formula (h), (j) or (k): <IMAGE> (h) <IMAGE> (j) <IMAGE> (k) and wherein the remaining variables are as defined herein. |
